Who bills the most Injection, ocrelizumab, 1 mg (J2350) to Medicare in Florida?
Medicare Part B FFS · CY2024 · as published by CMS4 physician groups billed Injection, ocrelizumab, 1 mg (J2350) to Medicare fee-for-service in Florida in 2024; independent (non-hospital-affiliated) groups deliver 0%.
J2350 — Injection, ocrelizumab, 1 mg · Source: CMS Medicare Physician & Other Practitioners PUF (Part B), CY2024 release. Medicare fee-for-service only.
Snapshot covers the whole Florida market — the table below shows the top 100 groups (free tier).
Medicare fee-for-service covers 43% of Medicare in Florida; Medicare Advantage penetration 48% → 57% since 2020.
| # | Physician group | City | St | Specialty | Providers | J2350 svcs | Share* | Phone |
|---|---|---|---|---|---|---|---|---|
| 1 | NEUROSCIENCE CONSULTANTS LLP | MIAMI | FL | NEUROLOGY | 104 | 39,600 | 33.6% | (305) 596-2080 |
| 2 | FLORIDA HOSPITAL MEDICINE SERVICES, LLC | FORT LAUDERDALE | FL | INTERNAL MEDICINE | 272 | 14,400 | 12.2% | (954) 355-4400 |
| 3 | FLORIDA NEUROLOGY GROUP P L | FORT MYERS | FL | NEUROLOGY | 10 | 11,700 | 9.9% | (941) 936-3554 |
| 4 | MS AND NEUROMUSCULAR CENTER OF EXCELLENCE LLC | CLEARWATER | FL | NEUROLOGY | 6 | 11,400 | 9.7% | (813) 855-2900 |
*Share of Florida's disclosed Medicare-FFS services for J2350, counted once per clinician. Volume is placed in the state it was billed from, so this page ranks the groups actually billing J2350 in Florida — including groups registered elsewhere ("City" is each group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group.
How to read this. Figures are Medicare fee-for-service only — not all-payer — from the CMS Medicare Physician & Other Practitioners Public Use File (Part B), CY2024 release. CMS suppresses any provider×code row under 11 beneficiaries, so a missing group means "suppressed," never zero. "Charges" are provider-submitted amounts, not payments. Groups are ranked by measured service volume attributed to clinicians in exactly one group — clinicians affiliated with several groups are listed in rosters but never volume-attributed to a single group — a direct read of the public record, not a rating or quality score. Full method: Methods & Sources.
Comparing against an all-payer estimate?
These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →